ClearVisc Ophthalmic Viscosurgical Device 25 mg Sodium Hyaluronate is utilized in ophthalmic surgeries, such as cataract operations, to maintain anterior chamber stability and protect intraocular tissues. Its viscoelastic properties facilitate surgical maneuvers by cushioning and maintaining space, minimizing trauma to the corneal endothelium. This device ensures an optimal surgical environment by providing clarity and improving precision during procedures, ultimately enhancing patient outcomes and recovery.

ClearVisc is an advanced ophthalmic viscosurgical device (OVD) formulated to provide superior performance in anterior segment surgeries, especially cataract procedures. Carefully crafted by Bausch & Lomb Americas, ClearVisc delivers optimal support through its high-quality sodium hyaluronate composition, ensuring seamless and effective ocular surgeries for both medical professionals and patients. Its non-inflammatory, biocompatible properties represent the forefront of ophthalmic innovation.

Details and Features:

• Concentration and Composition: Contains 25 mg of high molecular weight sodium hyaluronate per mL to ensure excellent viscoelasticity.
  
• Packaging: Comes in a sterilized, ready-to-use syringe for ease of application.
  
• Clarity and Consistency: Offers exceptional clarity and optimal consistency to maintain space within the anterior chamber during surgery.
  
• Biocompatibility: Crafted to minimize inflammation and ensure patient comfort post-operation.
  
• Versatile Compatibility: Suitable for a broad range of anterior segment surgeries beyond cataract procedures, including corneal transplants and glaucoma surgeries.

Mechanism of Action:

ClearVisc's mechanism of action hinges on its unique viscoelastic properties. The sodium hyaluronate within ClearVisc acts as a cohesive gel, providing mechanical support during anterior chamber maintenance. Upon injection, it creates a protective cushion for sensitive intraocular tissues, maintains space for surgical instruments, and helps manage intraocular pressure variances. These properties facilitate a safer and more controlled surgical environment, ultimately minimizing trauma to ocular structures.

Directions:

• 1. Surgeon's Preparation: Prior to the procedure, ensure all surgical instruments and hands are adequately sterilized.
  
• 2. Application: ClearVisc should be injected carefully into the anterior chamber, maintaining a steady hand to prevent any rapid increase in intraocular pressure.
  
• 3. Usage During Surgery: Use as needed to maintain space and maneuverability of tissues during the surgical procedure.
  
• 4. Removal: At the conclusion of the surgery, remove ClearVisc according to standard surgical protocol using irrigation/aspiration techniques.

Warnings:

• Professional Use Only: Designed solely for use by trained ophthalmic surgeons.
  
• Sterility Assurance: Do not use if the sterile packaging is damaged or compromised.
  
• Single-Use Device: To prevent contamination and infection, discard any unused portions.
  
• Storage Conditions: Store at controlled room temperature and avoid freezing or exposure to direct sunlight.

Side Effects:

While ClearVisc is generally well-tolerated, potential side effects may include:

• Transient Increase in Intraocular Pressure (IOP): Monitor IOP post-application and manage appropriately.
  
• Rare Hypersensitivity Reactions: Be vigilant for any signs of allergic reaction and address swiftly.
  
• Injection Site Irritation: Minor irritation may occur, typically resolving without intervention.

The ClearVisc Ophthalmic Viscosurgical Device exemplifies Bausch & Lomb Americas' commitment to enhancing surgical excellence and patient care, providing the ophthalmic community with a reliable and high-performing choice.